For GLP-1 receptor agonists specifically, adherence challenges are a major concern, as these medications require long-term use to achieve meaningful health benefits in chronic conditions like diabetes and obesity.
Solution developers have a key role to play in mapping the full patient experience and providing patients with the tools and knowledge needed to overcome common hurdles and maintain high rates of compliance. Doing so will benefit both patients and innovators.
Get your IV treatment from wherever you are. These top companies provide mobile IV therapy administered by experienced nurses in NYC and beyond.
Losing these retail medication outlets creates more than just pharmacy deserts. In many low-income and underserved areas, drugstores also serve as grocery stores and hubs for essential services, and hence their closures mean communities lose crucial access points for a variety of goods and services.
By integrating digitization and machine learning, there is an opportunity to deliver personalized care to all patients and scale precision dosing with minimal physician involvement, maximizing the effectiveness and accessibility of these drugs.
Through their alliance, Medisafe will deliver real-time interventions to help patients stay adherent and will alert Lash Group's clinicians when patients are considered "at-risk."
The New York City startup will use the financing, which came from investors like AXA Venture Partners, to expand its team and meet the increasing market demand.
To ensure effective cost mitigation, employers can’t wait for the market to adjust — they have to punch first.
As part of the collaboration. Medisafe's digital health tool will be used for Merck KGaA's drugs spanning Type 2 diabetes, thyroid disorders, and cardiovascular diseases.
The expanded service is designed to provide pharma companies with information that can help inform new strategies and tactics to improve patient engagement.
Can using wireless technology, financial incentives and social support improve medication adherence in heart attack survivors? A recent study published in JAMA Internal Medicine dives in.
A Medisafe infographic illustrates how the digital health startup is using de-identified data to visualize when people are most and least likely to take their medication.
Healthcare is drowning in chaos—from scattered data to burnout-inducing tasks. Discover how smarter workflows and real-time insights can rescue care teams and transform patient outcomes.
C2b solutions' approach stems from a belief that self-assessments to identify values, interests and lifestyles of patients are essential to knowing what really motivates and influences them.
In the next few years new products that combine drugs with digital experiences will begin to appear and will likely be more effective than regular drugs, says Chris Hogg of Propeller Health, a speaker at the upcoming MedCity ENGAGE conference in San Diego.
Medisafe's new channel for pharma companies is aimed at helping drug developers better understand adherence dynamics and make it easier to tweak their guidance for patients and physicians.